CSS
APLT

Cubist Systematic Strategies’s Applied Therapeutics APLT Stock Holding History

Cubist Systematic Strategies’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-163,072
Closed -$1.11M – 2940
2024
Q1 		$1.11M Buy
163,072
+104,475
+178% +$469K 0.01% 2083
2023
Q4 		$196K Buy
58,597
+54,085
+1,199% +$135K ﹤0.01% 3012
2023
Q3 		$11.2K Buy
+4,512
New +$7.44K ﹤0.01% 3141
2022
Q4 		– Sell
-4,038
Closed -$4K – 4221
2022
Q3 		$4K Hold
4,038
– – ﹤0.01% 4326
2022
Q2 		$4K Hold
4,038
– – ﹤0.01% 4301
2022
Q1 		$9K Sell
4,038
-3,388
-46% -$9.07K ﹤0.01% 3498
2021
Q4 		$66K Buy
7,426
+3,407
+85% +$44.7K ﹤0.01% 3275
2021
Q3 		$67K Buy
+4,019
New +$69.4K ﹤0.01% 2801
2021
Q2 		– Sell
-2,510
Closed -$47K – 2907
2021
Q1 		$47K Sell
2,510
-7,249
-74% -$156K ﹤0.01% 2739
2020
Q4 		$215K Sell
9,759
-3,782
-28% -$78.7K ﹤0.01% 2205
2020
Q3 		$281K Buy
13,541
+12,638
+1,400% +$329K ﹤0.01% 2012
2020
Q2 		$33K Buy
+903
New +$37.8K ﹤0.01% 2294

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's APLT Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 163,072 shares — an estimated $1.11M sold.

Cubist Systematic Strategies first reported a position in APLT in Q2 2020 and held it in 12 quarters. The position peaked at $1.11M in Q1 2024. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 163,072 Applied Therapeutics shares in Q2 2024, an estimated $1.11M.
  • Cubist Systematic Strategies first reported a position in Applied Therapeutics in Q2 2020 and held it in 12 quarters.
  • Cubist Systematic Strategies's Applied Therapeutics position peaked at $1.11M in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.